Researchers expand knowledge of converting plant enzymes into biofuel
Researchers are one step closer towards converting plant material into biofuels with a newly discovered method of optimising plant enzymes through bioengineering.
Ampcontrol claims top spot at 2024 Business Hunter Awards for Manufacturing Excellence
Ampcontrol, a leading manufacturer in the Hunter region, was named the winner of the prestigious President’s Award at the 2024 Business Hunter Awards, held at the Newcastle Exhibition Centre (NEX) on Friday, 13 September 2024.
Amaero signs agreement with Rio Tinto to collaborate on alloy for 3D printing
Metal additive manufacturer, Amaero International Limited (“Amaero”), has entered into an Agreement to collaborate with Rio Tinto on the development of the supply chain for...
Victorian businesses back proposed 10-year manufacturing strategy, says survey
A majority of businesses in Victoria expressed their support for the state’s proposed 10-year manufacturing strategy, according to a survey conducted by the Victorian...
Public feedback sought to help address plastic pollution in NSW
Businesses and the community in New South Wales are being encouraged to provide feedback on the state government’s efforts to mitigate plastic pollution.
RAN taps Ocius Bluebottles for 5 Australian-made USVs
New South Wales-based maritime company Ocius Bluebottles has secured a contract with the Royal Australian Navy (RAN) to provide five locally assembled uncrewed surface vessels (USV) in 2023.
Argosy joins European Raw Materials Alliance
Argosy Minerals Limited (ASX:AGY) has been accepted as a primary raw material partner of the European Raw Materials Alliance (ERMA).
Established in September 2020 by...
Guarda Systems commends ban on engineered stone, but calls for new enhanced regulations
Guarda Systems, an environmental health and safety technology company, said the national ban on engineered stone in Australia is a step in the right direction but noted the urgent need for new and improved regulations.
Vaxxas to develop first room-temperature stable RSV vaccine with NIH license
Vaxxas, a clinical-stage biotechnology company known for its innovative high-density microarray patch (HD-MAP) vaccination platform, has secured a worldwide license from the United States National Institutes of Health (NIH) for a next-generation vaccine antigen aimed at combating Respiratory Syncytial Virus (RSV).
Australian industry slips further into contraction in July, says Ai Group
The Ai Group Australian Industry Index posted a rating of -14.7 points in July, indicating contractionary conditions and marking the index’s 15th month in the negative territory.